Scientists test 'One-Time' gene fix for devastating childhood disease
NCT ID NCT05665166
Summary
This is a first-in-human safety study testing a new gene therapy for young boys with a severe form of Hunter syndrome, a rare genetic disorder. Researchers will collect a child's own stem cells, add a working copy of a missing gene in the lab, and return the cells to the child's body. The goal is to see if the body can then produce the missing enzyme itself, which may help treat symptoms, including those affecting the brain. Five young patients will be closely followed for at least two years to check safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOPOLYSACCHARIDOSIS II are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Manchester University Foundation Trust
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.